Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mesenchymal Stem Cells for Multiple Sclerosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by Karolinska Institutet
Sponsor:
Information provided by (Responsible Party):
Ellen Iacobaeus, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01730547
First received: November 9, 2012
Last updated: February 11, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)